tiprankstipranks
TG Therapeutics (TGTX)
:TGTX
US Market

TG Therapeutics (TGTX) Income Statement

Compare
1,958 Followers

TG Therapeutics Income Statement

Last quarter (Q4 2024), TG Therapeutics's total revenue was $108.19M, an increase of 146.04% from the same quarter last year. In Q4, TG Therapeutics's net income was $23.33M. See TG Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 329.00M$ 233.66M$ 2.79M$ 6.69M$ 152.00K
Gross Profit
$ 290.52M$ 219.11M$ 2.52M$ 5.90M$ -222.00K
Operating Expenses
$ 248.59M$ 198.90M$ 195.36M$ 350.67M$ 273.75M
Depreciation and Amortization
$ 280.00K$ 423.00K$ 515.00K$ 494.00K$ 374.00K
EBITDA
$ 49.90M$ 26.10M$ -187.63M$ -341.97M$ -272.68M
Operating Income
$ 41.93M$ 20.63M$ -192.84M$ -344.77M$ -273.59M
Other Income/Expenses
$ -16.34M$ -7.57M$ -5.50M$ -3.33M$ -5.79M
Pretax Income
$ 25.59M$ 13.06M$ -198.34M$ -348.10M$ -279.38M
Net Income
$ 23.38M$ 12.67M$ -203.83M$ -355.55M$ -285.88M
Per Share Metrics
Basic EPS
$ 0.16$ 0.09$ -1.51$ -2.69$ -2.48
Diluted EPS
$ 0.15$ 0.09$ -1.51$ -2.69$ -2.48
Weighted Average Shares Outstanding
145.32M 141.96M 135.41M 132.22M 115.33M
Weighted Average Shares Outstanding (Diluted)
160.34M 148.51M 135.41M 132.22M 115.33M
Currency in USD

TG Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis